Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Aviragen Therapeutic (AVIR)

0.591 +0.011 (+1.897%)

6/23/2017  12:50pm

Open:

0.578

Pre. Close:

0.580

High:

0.609

Low:

0.550

Volume:

762,213

Market Cap:

22.84M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.64 - 0.64

0.64 - 0.65

Low:

0.46 - 0.46

0.46 - 0.47

Close:

0.57 - 0.58

0.58 - 0.59

Technical analysis  (as of: 2017-06-23 12:42:52 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.75     One year: 0.87

Support:

Support1: 0.51    Support2: 0.43

Resistance:

Resistance1: 0.64    Resistance2: 0.75

Pivot:

0.50

Moving Averages:

MA(5): 0.54     MA(20): 0.50

MA(100): 0.64     MA(250): 1.10

MACD:

MACD(12,26): 0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 57.34     %D(3): 44.93

RSI:

RSI(14): 65.54

52-Week:

High: 2.000  Low: 0.431  Change(%): -57.1

Average Vol(K):

3-Month: 269  10-Days 959

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AVIR has closed above the upper band by 2.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Jun 2017 13:41:15 GMT
Aviragen Therapeutics Inc. (NASDAQ:AVIR)

Wed, 04 May 2016 01:46:26 GMT
0.5978

Wed, 27 Apr 2016 14:31:09 GMT
Biota Pharmaceuticals Is Now Aviragen Therapeutics

Fri, 03 Feb 2017 02:15:00 GMT
Aviragen Therapeutics' (AVIR) CEO Joseph Patti on Q2 2017 Results - Earnings ...

Sat, 05 Nov 2016 21:00:00 GMT
Aviragen Therapeutics' (AVIR) CEO Joseph Patti on Q1 2017 Results - Earnings ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

38.65

Shares Float (M)

30.74

% Held by Insiders

% Held by Institutions

Shares Short (K)

267

Shares Short Prior Month (K)

258

Stock Financials

EPS

-0.790

EPS Est. Current Year

-0.810

EPS Est. Next Year

-0.860

EPS Est. Next Quarter

-0.280

Forward EPS

-0.866

Book Value (p.s.)

0.630

PEG Ratio

Profit Margin

Operating Margin

-306.45

Return on Assets (ttm)

-32.8

Return on Equity (ttm)

-79.3

Qtrly Rev. Growth

-7.5

Gross Profit (p.s.)

0.241

Sales Per Share

EBITDA (p.s.)

-0.754

Qtrly Earnings Growth

Operating Cash Flow (M)

-30.10

Levered Free Cash Flow (M)

-17.38

FoxReading.com

Valuation

P/E

-0.75

P/E Growth Ratio

0.02

P/BV

0.94

P/S

95417176.00

P/CF

-0.76

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-11-08

Ex-Dividend Date

2012-11-09

Forward Dividend

Last Split Date

2012-11-09

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.